Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0232 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0034 | 0.0612 | 0.0263 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0125 | 0.4933 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0173 | 0.7178 | 0.7073 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0173 | 0.7178 | 0.7073 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0044 | 0.1069 | 0.0487 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0044 | 0.1069 | 0.0588 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.0044 | 0.1069 | 0.1069 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0185 | 0.7746 | 0.7663 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0034 | 0.0597 | 0.0247 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0125 | 0.4924 | 0.4735 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0156 | 0.6374 | 0.6239 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0173 | 0.7178 | 0.7073 |
Echinococcus granulosus | serine protein kinase ATM | 0.0044 | 0.1069 | 0.1069 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0185 | 0.7746 | 0.7663 |
Trichomonas vaginalis | AGC family protein kinase | 0.0034 | 0.0612 | 0.0263 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0078 | 0.268 | 0.2605 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0044 | 0.1069 | 0.0737 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0198 | 0.839 | 0.833 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0023 | 0.01 | 0.01 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0034 | 0.0597 | 0.0597 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0078 | 0.268 | 0.2285 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0232 | 1 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0232 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.1231 | 0.0904 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0232 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0232 | 1 | 1 |
Trypanosoma cruzi | Protein kinase B | 0.0023 | 0.01 | 0.01 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0185 | 0.7756 | 0.7609 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.011 | 0.4195 | 0.3816 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0044 | 0.1069 | 0.0588 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0232 | 1 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0023 | 0.01 | 0.01 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0029 | 0.0359 | 0.0359 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.0044 | 0.1069 | 0.1069 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.268 | 0.2407 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0034 | 0.0597 | 0.0597 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0049 | 0.1307 | 0.0984 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0185 | 0.7746 | 0.7663 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0232 | 1 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0232 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0173 | 0.7178 | 0.7073 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0137 | 0.5502 | 0.5335 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0125 | 0.4933 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0139 | 0.5567 | 0.5402 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0173 | 0.7178 | 0.7073 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1307 | 0.0984 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.268 | 0.2407 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0034 | 0.0612 | 0.0263 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0173 | 0.7178 | 0.7073 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0078 | 0.268 | 0.268 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0232 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0034 | 0.0612 | 0.0263 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0044 | 0.1069 | 0.0737 |
Brugia malayi | Protein kinase domain containing protein | 0.0034 | 0.0612 | 0.0106 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0151 | 0.6136 | 0.5992 |
Entamoeba histolytica | protein kinase rad3, putative | 0.0044 | 0.1069 | 0.1069 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0232 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.268 | 0.2407 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0078 | 0.268 | 0.268 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0185 | 0.7756 | 0.7756 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0044 | 0.1069 | 0.1069 |
Entamoeba histolytica | protein kinase, putative | 0.0034 | 0.0612 | 0.0612 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0062 | 0.1941 | 0.1641 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0232 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.268 | 0.2407 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0597 | 0.0501 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0078 | 0.268 | 0.2407 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0232 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0044 | 0.1069 | 0.1069 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0034 | 0.0612 | 0.0263 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0078 | 0.268 | 0.2203 |
Toxoplasma gondii | FATC domain-containing protein | 0.0044 | 0.1069 | 0.0837 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0096 | 0.3561 | 0.3141 |
Giardia lamblia | GTOR | 0.0232 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.1069 | 0.0737 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0232 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0078 | 0.268 | 0.2407 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0078 | 0.268 | 0.2203 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0139 | 0.5567 | 0.5402 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0078 | 0.268 | 0.268 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0078 | 0.268 | 0.268 |
Entamoeba histolytica | hypothetical protein | 0.0044 | 0.1069 | 0.1069 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0021 | 0 | 0.5 |
Brugia malayi | FAT domain containing protein | 0.0034 | 0.0597 | 0.009 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0125 | 0.4933 | 0.4745 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0044 | 0.1069 | 0.1069 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0137 | 0.5502 | 0.5335 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0049 | 0.1307 | 0.1194 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0185 | 0.7756 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0125 | 0.4933 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0185 | 0.7746 | 0.7663 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0023 | 0.01 | 0.01 |
Trichomonas vaginalis | AGC family protein kinase | 0.0034 | 0.0612 | 0.0263 |
Trichomonas vaginalis | AGC family protein kinase | 0.0034 | 0.0612 | 0.0263 |
Trichomonas vaginalis | AGC family protein kinase | 0.0034 | 0.0612 | 0.0263 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0125 | 0.4924 | 0.4735 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0139 | 0.5567 | 0.5402 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0232 | 1 | 1 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0032 | 0.0511 | 0.0159 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0185 | 0.7746 | 0.7663 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0023 | 0.01 | 0.01 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0044 | 0.1069 | 0.0979 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.0044 | 0.1069 | 0.0979 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0044 | 0.1069 | 0.0737 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0232 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0173 | 0.7178 | 0.7073 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0023 | 0.01 | 0.01 |
Entamoeba histolytica | protein kinase, putative | 0.0034 | 0.0612 | 0.0612 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0597 | 0.0247 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0173 | 0.7178 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0125 | 0.4924 | 0.4735 |
Entamoeba histolytica | protein kinase, putative | 0.0032 | 0.0511 | 0.0511 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.0044 | 0.1069 | 0.1069 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.